A Clinical Trial to Evaluate the Safety and Effectiveness of OLIZ, a Photobiomodulation Medical Device for Surgical Site Pain Relief in Patients After Total Knee Arthroplasty

NANot yet recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

August 20, 2025

Primary Completion Date

January 30, 2026

Study Completion Date

June 30, 2026

Conditions
Postoperative Pain Management During Rehabilitation in Patients Undergoing Total Knee Arthroplasty
Interventions
DEVICE

OLIZ Photobiomodulation Device

OLIZ device utilizes dual-wavelength technology combining specific red (660nm) and near-infrared (850nm) light parameters optimized for post-surgical tissue healing. The device features controlled power density, precise treatment duration protocols, and targeted application to knee arthroplasty surgical sites. Treatment parameters include specific irradiance levels, treatment session duration of 15 minutes, and 3 times of daily application frequency designed.

All Listed Sponsors
collaborator

Inje University

OTHER

collaborator

InjeUniversityIlsanPaikHospital

UNKNOWN

collaborator

Gangnam Severance Hospital

OTHER

collaborator

National Medical Center, Seoul

OTHER

collaborator

National Health Insurance Service Ilsan Hospital

OTHER

collaborator

Korea University Anam Hospital

OTHER

collaborator

Samsung Medical Center

OTHER

collaborator

The Catholic University of Korea Uijeongbu St.Marys Hostpial

UNKNOWN

lead

LTBIO Co., Ltd.

INDUSTRY

NCT07091773 - A Clinical Trial to Evaluate the Safety and Effectiveness of OLIZ, a Photobiomodulation Medical Device for Surgical Site Pain Relief in Patients After Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter